Erchonia EVRL Laser for Foot Pain Relief in Idiopathic Peripheral Neuropathy
Erchonia® EVRL™
Nervous System Diseases+1
+ Neuritis
+ Neuromuscular Diseases
Treatment Study
Summary
Study start date: May 1, 2025
Actual date on which the first participant was enrolled.This clinical study is focused on testing a device called the Erchonia® EVRL™, which is designed to help relieve foot pain caused by idiopathic peripheral neuropathy. Idiopathic peripheral neuropathy is a condition where people experience pain in their feet due to unknown reasons. The goal is to see if this device, which is used at home, can effectively reduce foot pain for those dealing with this condition. This study is important because it explores a new way to manage pain without needing to go to a clinic, offering a convenient solution for individuals suffering from this type of neuropathy. Participants in the study will use the Erchonia® EVRL™ device themselves at home. They will administer the treatment by using the laser device as directed. The study observes how well the device works in providing temporary pain relief. There is no mention of specific risks or benefits in the description, but it implies that the device is non-invasive since it uses laser technology, which is often considered safe for home use. The study does not involve comparing the device to any other treatment, focusing only on the effects of the Erchonia® EVRL™.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.32 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 22 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location